Immunotherapy Updates in Advanced Hepatocellular Carcinoma.
Amisha Singh1, Ryan J Beechinor2, Jasmine C Huynh3
1Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Cancers
|May 5, 2021
Summary
Hepatocellular carcinoma (HCC) immunotherapy shows promise. Combination therapies like atezolizumab and bevacizumab are advancing treatment, with CAR-T cell therapy emerging as a future option for advanced liver cancer.
Area of Science:
- Oncology
- Immunology
- Hepatology
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- Tumor microenvironment and hepatic immune system dynamics significantly influence HCC development and treatment resistance.
- Immunotherapy offers potential to enhance anti-tumor activity and overcome immune tolerance in HCC.
Purpose of the Study:
- To review the impact of immunotherapy on advanced HCC outcomes.
- To discuss ongoing clinical trials for novel combination immunotherapy strategies in HCC.
- To evaluate emerging therapies like CAR-T cell therapy for HCC.
Main Methods:
- Review of current literature on immunotherapy for advanced HCC.
- Analysis of clinical trial data, including the IMbrave150 study.
- Discussion of preliminary findings for novel therapeutic approaches.
Main Results:
- Atezolizumab and bevacizumab combination therapy (IMbrave150) has set a new standard for first-line treatment in advanced HCC.
- Multiple ongoing trials are exploring additional front-line immunotherapy combinations.
- Chimeric antigen receptor (CAR-T) cell therapy shows preliminary promise for advanced HCC.
Conclusions:
- Immunotherapy, particularly combination strategies, is transforming advanced HCC treatment.
- Ongoing research and clinical trials are expanding therapeutic options for HCC.
- CAR-T cell therapy represents a potential future direction for advanced HCC management.
Keywords:
CTLA-4PD-1PD-L1chimeric antigen receptorhepatocellular carcinomaimmune checkpoint inhibitorsimmunotherapyMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
804
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
804
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
01:30Cancer Vaccines
602
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
602
02:49Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:50Combination Therapies and Personalized Medicine
5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K